New approaches in the treatment of hepatitis C

doi:10.3748/wjg.v22.i4.1421

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (19386)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

1559

WORD

427

HTML

12895

Tables (1-4)

250

Sum=15131

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

399

Download

815

Sum=1214

Publishing Process of This Article

Item

Count

Browse

1281

Download

1760

Sum=3041

Jan 28, 2016 (publication date) through Feb 7, 2025

Times Cited of This Article

Times Cited (114)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jan 28, 2016; 22(4): 1421-1432
Published online Jan 28, 2016. doi: 10.3748/wjg.v22.i4.1421

Table 2 Recommendations for therapy in patients with genotype 1b

Patient characterization	Recommended	Duration	Scientific evidence	Real-world evidence
Genotype 1b naive noncirrhotic	SOF + LDV	12	ION-1
	SOF + LDV (CV < 6 × 10⁶ UI/mL)	8	ION-3
	OBV + PTVR + DSV	12	SAPHIRE I PEARL
	SOF + SIM	12	COSMOS	TARGET TRIO
	SOF + DCV	12
	SOF + PEG + RBV	12	NEUTRINO
Genotype 1b naive cirrhotic	SOF + LDV	12	ION-1
	OBV + PTVR + DSV + RBV	12	TURQUOISE-II PEARL
	SOF + SIM	12	COSMOS
	SOF + DCV	12
	SOF + PEG + RBV	12	NEUTRINO
Genotype 1b retreated noncirrhotic	SOF + LDV	12	ION-2
	OBV + PTVR + DSV	12	SAPHIRE-II
	SOF + SIM	12	COSMOS
	SOF + DCV	12/24
Genotype 1b retreated cirrhotic	SOF + LDV + RBV	12	ION-2
	SOF + LDV	24	ION-2
	OBV + PTVR + DSV + RBV	12	TURQUOISE-II PEARL
	SOF + SIM	12	COSMOS
	SOF + DVC	24

SOF: Sofosbuvir; LDV: Ledipasvir.

Citation: González-Grande R, Jiménez-Pérez M, González Arjona C, Mostazo Torres J. New approaches in the treatment of hepatitis C. World J Gastroenterol 2016; 22(4): 1421-1432
URL: https://www.wjgnet.com/1007-9327/full/v22/i4/1421.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i4.1421